Associated Papers
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma.
Seidel P et al.
Jci Insight, 2022
36413415 (PubMed )
Supplement: jciinsight-7-156087-s060.xlsx › 769P
p53 mitigates the effects of oncogenic HRAS in urothelial cells via the repression of MCOLN1.
Jung J et al.
Iscience, 2021
34222845 (PubMed )
Supplement: mmc6.xlsx › Supplementary_Table_5
Analysis of CRISPR-Cas9 screens identifies genetic dependencies in melanoma.
Christodoulou E et al.
Pigment Cell & Melanoma Research, 2021
32767816 (PubMed )
Supplement: PCMR-34-122-s006.xlsx › Sheet1
Select a paper to view details